Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

related to degree

  • Li, Julia Su Zhou, Ph.D. in Biology, Scripps Research 2013 - 2018

authors

  • Ruiz, C.
  • Li, Julia Su Zhou
  • Luttgen, M. S.
  • Kolatkar, A.
  • Kendall, J. T.
  • Flores, E.
  • Topp, Z.
  • Samlowski, W. E.
  • McClay, E.
  • Bethel, Kelly
  • Ferrone, S.
  • Hicks, J.
  • Kuhn, Peter

publication date

  • February 2015

journal

  • Physical Biology  Journal

abstract

  • Purpose. Circulating melanoma cells (CMCs) constitute a potentially important representation of time-resolved tumor biology in patients. To date, genomic characterization of CMCs has been limited due to the lack of a robust methodology capable of identifying them in a format suitable for downstream characterization. Here, we have developed a methodology to detect intact CMCs that enables phenotypic, morphometric and genomic analysis at the single cell level. Experimental design. Blood samples from 40 metastatic melanoma patients and 10 normal blood donors were prospectively collected. A panel of 7 chondroitin sulfate proteoglycan 4 (CSPG4)-specific monoclonal antibodies (mAbs) was used to immunocytochemically label CMCs. Detection was performed by automated digital fluorescence microscopy and multi-parametric computational analysis. Individual CMCs were captured by micromanipulation for whole genome amplification and copy number variation (CNV) analysis. Results. Based on CSPG4 expression and nuclear size, 1-250 CMCs were detected in 22 (55%) of 40 metastatic melanoma patients (0.5-371.5 CMCs ml(-1)). Morphometric analysis revealed that CMCs have a broad spectrum of morphologies and sizes but exhibit a relatively homogeneous nuclear size that was on average 1.5-fold larger than that of surrounding PBMCs. CNV analysis of single CMCs identified deletions of CDKN2A and PTEN, and amplification(s) of TERT, BRAF, KRAS and MDM2. Furthermore, novel chromosomal amplifications in chr12, 17 and 19 were also found. Conclusions. Our findings show that CSPG4 expressing CMCs can be found in the majority of advanced melanoma patients. High content analysis of this cell population may contribute to the design of effective personalized therapies in patients with melanoma.

subject areas

  • Aged
  • Aged, 80 and over
  • Cell Line, Tumor
  • Female
  • Genome, Human
  • Genomics
  • Humans
  • Male
  • Melanoma
  • Middle Aged
  • Neoplasm Staging
  • Neoplastic Cells, Circulating
scroll to property group menus

Research

keywords

  • CSPG4
  • DNA copy number variation
  • circulating melanoma cells
  • metastatic melanoma
  • nuclear morphometry
scroll to property group menus

Identity

PubMed Central ID

  • PMC5023009

International Standard Serial Number (ISSN)

  • 1478-3967

Digital Object Identifier (DOI)

  • 10.1088/1478-3975/12/1/016008

PubMed ID

  • 25574741
scroll to property group menus

Additional Document Info

volume

  • 12

issue

  • 1

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support